View source for CTAG1B

<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes 
| require_manual_inspection = no 
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}

<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
 | image =  
 | image_source =  
 | PDB = 
 | Name = Cancer/testis antigen 1B
 | HGNCid = 2491
 | Symbol = CTAG1B
 | AltSymbols =; CTAG; CTAG1; ESO1; LAGE-2; LAGE2B; NY-ESO-1; CAMEL; ESO2; LAGE-1; LAGE-2b; MGC138724; MGC3803; LAGE2A
 | OMIM = 300156
 | ECnumber =  
 | Homologene = 37469
 | MGIid =  
 | GeneAtlas_image1 = PBB_GE_CTAG1B_207337_at_tn.png
 | GeneAtlas_image2 = PBB_GE_CTAG1B_210546_x_at_tn.png
 | GeneAtlas_image3 = PBB_GE_CTAG1B_211674_x_at_tn.png
 | Function = {{GNF_GO|id=GO:0003674 |text = molecular_function}} 
 | Component = {{GNF_GO|id=GO:0005575 |text = cellular_component}} {{GNF_GO|id=GO:0005737 |text = cytoplasm}} {{GNF_GO|id=GO:0005813 |text = centrosome}} {{GNF_GO|id=GO:0016020 |text = membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}} 
 | Process = {{GNF_GO|id=GO:0008150 |text = biological_process}} 
 | Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 1485
    | Hs_Ensembl = ENSG00000126890
    | Hs_RefseqProtein = NP_001318
    | Hs_RefseqmRNA = NM_001327
    | Hs_GenLoc_db =  
    | Hs_GenLoc_chr = X
    | Hs_GenLoc_start = 153533440
    | Hs_GenLoc_end = 153535047
    | Hs_Uniprot = O75638
    | Mm_EntrezGene =  
    | Mm_Ensembl =  
    | Mm_RefseqmRNA =  
    | Mm_RefseqProtein =  
    | Mm_GenLoc_db =  
    | Mm_GenLoc_chr =  
    | Mm_GenLoc_start =  
    | Mm_GenLoc_end =  
    | Mm_Uniprot =  
  }}
}}
'''Cancer/testis antigen 1B''', also known as '''CTAG1B''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: CTAG1B cancer/testis antigen 1B| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=1485| accessdate = }}</ref>

<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
| section_title = 
| summary_text = 
}}

==References==
{{reflist|2}}
==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading 
| citations = 
*{{cite journal  | author=Scanlan MJ, Gure AO, Jungbluth AA, ''et al.'' |title=Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. |journal=Immunol. Rev. |volume=188 |issue=  |pages= 22-32 |year= 2003 |pmid= 12445278 |doi=  }}
*{{cite journal  | author=Chen YT, Scanlan MJ, Sahin U, ''et al.'' |title=A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=94 |issue= 5 |pages= 1914-8 |year= 1997 |pmid= 9050879 |doi=  }}
*{{cite journal  | author=Chen YT, Boyer AD, Viars CS, ''et al.'' |title=Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. |journal=Cytogenet. Cell Genet. |volume=79 |issue= 3-4 |pages= 237-40 |year= 1998 |pmid= 9605863 |doi=  }}
*{{cite journal  | author=Lethé B, Lucas S, Michaux L, ''et al.'' |title=LAGE-1, a new gene with tumor specificity. |journal=Int. J. Cancer |volume=76 |issue= 6 |pages= 903-8 |year= 1998 |pmid= 9626360 |doi=  }}
*{{cite journal  | author=Wang RF, Johnston SL, Zeng G, ''et al.'' |title=A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. |journal=J. Immunol. |volume=161 |issue= 7 |pages= 3598-606 |year= 1998 |pmid= 9759882 |doi=  }}
*{{cite journal  | author=De Smet C, Lurquin C, Lethé B, ''et al.'' |title=DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. |journal=Mol. Cell. Biol. |volume=19 |issue= 11 |pages= 7327-35 |year= 1999 |pmid= 10523621 |doi=  }}
*{{cite journal  | author=Schultz-Thater E, Noppen C, Gudat F, ''et al.'' |title=NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. |journal=Br. J. Cancer |volume=83 |issue= 2 |pages= 204-8 |year= 2000 |pmid= 10901371 |doi= 10.1054/bjoc.2000.1251 }}
*{{cite journal  | author=Rimoldi D, Rubio-Godoy V, Dutoit V, ''et al.'' |title=Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. |journal=J. Immunol. |volume=165 |issue= 12 |pages= 7253-61 |year= 2001 |pmid= 11120859 |doi=  }}
*{{cite journal  | author=Simpson JC, Wellenreuther R, Poustka A, ''et al.'' |title=Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. |journal=EMBO Rep. |volume=1 |issue= 3 |pages= 287-92 |year= 2001 |pmid= 11256614 |doi= 10.1093/embo-reports/kvd058 }}
*{{cite journal  | author=Jungbluth AA, Chen YT, Stockert E, ''et al.'' |title=Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. |journal=Int. J. Cancer |volume=92 |issue= 6 |pages= 856-60 |year= 2001 |pmid= 11351307 |doi= 10.1002/ijc.1282 }}
*{{cite journal  | author=Goydos JS, Patel M, Shih W |title=NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma. |journal=J. Surg. Res. |volume=98 |issue= 2 |pages= 76-80 |year= 2001 |pmid= 11397121 |doi= 10.1006/jsre.2001.6148 }}
*{{cite journal  | author=Aradhya S, Bardaro T, Galgóczy P, ''et al.'' |title=Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. |journal=Hum. Mol. Genet. |volume=10 |issue= 22 |pages= 2557-67 |year= 2002 |pmid= 11709543 |doi=  }}
*{{cite journal  | author=Zarour HM, Maillere B, Brusic V, ''et al.'' |title=NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells. |journal=Cancer Res. |volume=62 |issue= 1 |pages= 213-8 |year= 2002 |pmid= 11782380 |doi=  }}
*{{cite journal  | author=Satie AP, Rajpert-De Meyts E, Spagnoli GC, ''et al.'' |title=The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. |journal=Lab. Invest. |volume=82 |issue= 6 |pages= 775-80 |year= 2002 |pmid= 12065688 |doi=  }}
*{{cite journal  | author=Nagata Y, Ono S, Matsuo M, ''et al.'' |title=Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 16 |pages= 10629-34 |year= 2002 |pmid= 12138174 |doi= 10.1073/pnas.112331099 }}
*{{cite journal  | author=Resnick MB, Sabo E, Kondratev S, ''et al.'' |title=Cancer-testis antigen expression in uterine malignancies with an emphasis on carcinosarcomas and papillary serous carcinomas. |journal=Int. J. Cancer |volume=101 |issue= 2 |pages= 190-5 |year= 2002 |pmid= 12209997 |doi= 10.1002/ijc.10585 }}
*{{cite journal  | author=Peng LP, Liu HY, Ran YL, ''et al.'' |title=[Expression of NY-ESO-1 gene in human esophageal carcinoma and its cloning] |journal=Ai Zheng |volume=21 |issue= 5 |pages= 469-72 |year= 2003 |pmid= 12452034 |doi=  }}
*{{cite journal  | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal  | author=Gnjatic S, Atanackovic D, Jäger E, ''et al.'' |title=Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 15 |pages= 8862-7 |year= 2003 |pmid= 12853579 |doi= 10.1073/pnas.1133324100 }}
}}
{{refend}}

{{protein-stub}}
{{WikiDoc Sources}}